The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma

Modern Pathology

Volumn 15, Issue 11, 2002, Pages 1181-1190

  Aishima, Shin ichi ^a   Asayama, Yoshiki ^a   Taguchi, Ken ichi ^a   Sugimachi, Keishi ^a   Shirabe, Ken ^a   Shimada, Mitsuo ^a   Sugimachi, Keizo ^a   Tsuneyoshi, Masazumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Intrahepatic cholangiocarcinoma; Keratin 903; Prognostic marker

Indexed keywords

BIOLOGICAL MARKER; CYTOKERATIN 19; CYTOKERATIN 7; PROTEIN SUBUNIT;

ARTICLE; BILE DUCT CARCINOMA; CANCER GROWTH; CANCER SURVIVAL; CONTROLLED STUDY; DYSPLASIA; FEMALE; FETUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; INFANT; LIVER CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; MULTIVARIATE ANALYSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

AGED; AUTOPSY; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CHILD, PRESCHOOL; CHOLANGIOCARCINOMA; FEMALE; FETUS; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; KERATINS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0036860473     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MP.0000032537.82380.69     Document Type: Article

References (34)

1. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11-24.
2. Balaton AJ, Nehama-Sibony M, Gotheil C, Callard P, Baviera EE. Distinction between hepatocellular carcinoma, cholangiocarcinoma, and metastatic carcinoma based on immunohistochemical staining for carcinoembryonic antigen and for cytokeratin 19 on paraffin sections. J Pathol 1988;156:305-10.
3. Johnson DE, Herndier BG, Medeiros LJ, Warnke RA, Rouse RV. The diagnostic utility of the keratin profiles of hepatocellular carcinoma and cholangiocarcinoma. Am J Surg Pathol 1988;12:187-97.
4. Denk H, Krepler R, Lackinger E, Artlieb U, Franke WW. Biochemical and immunocytochemical analysis of the intermediate filament cytoskeleton in human hepatocellular carcinomas and in hepatic neoplastic nodules of mice. Lab Invest 1982;46:584-96.
5. Lai YS, Thung SN, Gerber MA, Chen ML, Schaffner F. Expression of cytokeratins in normal and diseased livers and in primary liver carcinomas. Arch Pathol Lab Med 1989;113:134-8.
6. Fischer HP, Altmannsberger M, Weber K, Osborn M. Keratin polypeptides in malignant epithelial liver tumors. Differential diagnostic and histogenetic aspects. Am J Pathol 1987;127:530-7.
7. Maeda T, Kajiyama K, Adachi E, Takenaka K, Sugimachi K, Tsuneyoshi M. The expression of cytokeratins 7, 19, and 20 in primary and metastatic carcinomas of the liver. Mod Pathol 1996;9:901-9.
8. Shimonishi T, Miyazaki K, Nakanuma Y. Cytokeratin profile relates to histological subtypes and intrahepatic cholangiocarcinioma and primary site of metastatic adenocarcinoma of liver. Histopathology 2000;37:55-63.
9. Rullier A, Le Bail B, Fawaz R, Blanc JF, Saric J, Bioulac-Sage P. Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis. Am J Surg Pathol 2000;24:870-6.
10. Van Eyken P, Desmet VJ. Cytokeratins and the liver. Liver 1993;13:113-22.
11. Gown AM, Vogel AM. Monoclonal antibodies to human intermediate filament proteins. II. Distribution of filament proteins in normal human tissues. Am J Pathol 1984;114:309-21.
12. Gown AM, Vogel AM. Monoclonal antibodies to human intermediate filament proteins. III. Analysis of tumors. Am J Clin Pathol 1985;84:413-24.
13. Van Eyken P, Sciot R, Paterson A, Callea F, Kew MC, Desmet VJ. Cytokeratin expression in hepatocellular carcinoma: An immunohistochemical study. Hum Pathol 1988;19:562-8.
14. Hurlimann J, Gardiol D. Immunohistochemistry in the differential diagnosis of liver carcinomas. Am J Surg Pathol 1991;15:280-8.
15. D'Errico A, Baccarini P, Fiorentino M, Ceccarelli C, Bonazzi C, Ponzetto A, et al. Histogenesis of primary liver carcinomas: Strengths and weaknesses of cytokeratin profile and albumin mRNA detection. Hum Pathol 1996;27:599-604.
16. Liver Cancer Study Group. The General Rules for the Clinical and Pathological Study of Primary Liver Cancer. 4th Ed. Tokyo: Kanehara Publications; 2000.
17. Maeda T, Takenaka K, Taguchi K, Kajiyama K, Shirabe K, Shimada M, et al. Adenosquamous carcinoma of the liver: Clinicopathologic characteristics and cytokeratin profile. Cancer 1997;80:364-71.
18. Kajiyama K, Maeda T, Takenaka K, Sugimachi K, Tsuneyoshi M. The significance of stromal desmoplasia in intrahepatic cholangiocarcinoma: A special reference of "scirrhous-type" and "nonscirrhous-type" growth. Am J Surg Pathol 1999;23:892-902.
19. Minervini MI, Demetris AJ, Lee RG, Carr BI, Madariaga J, Nalesnik MA. Utilization of hepatocyte-specific antibody in the immunocytochemical evaluation of liver tumors. Mod Pathol 1997;10:686-92.
20. Van Eyken P, Sciot R, Callea F, Van der Steen K, Moerman P, Desmet VJ. The development of the intrahepatic bile ducts in man: A keratin-immunohistochemical study. Hepatology 1988;8:1586-95.
21. Van Eyken P, Sciot R, Desmet V. Intrahepatic bile duct development in the rat: A cytokeratin-immunohistochemical study. Lab Invest 1988;59:52-9.
22. Shah KD, Gerber MA. Development of intrahepatic bile ducts in humans. Immunohistochemical study using monoclonal cytokeratin antibodies. Arch Pathol Lab Med 1989;113:1135-8.
23. Yamamoto M, Takasaki K, Nakano M, Saito A. Minute nodular intrahepatic cholangiocarcinoma. Cancer 1998;82:2145-9.
24. Okuda K, Kubo Y, Okazaki N, Arishima T, Hashimoto M. Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma: A study of 57 autopsy-proven cases. Cancer 1977;39:232-46.
25. Yamanaka N, Okamoto E, Ando T, Oriyama T, Fujimoto J, Furukawa K, et al. Clinicopathologic spectrum of resected extraductal mass-forming intrahepatic cholangiocarcinoma. Cancer 1995;76:2449-56.
26. Taguchi K, Aishima S, Asayama Y, Kajiyama K, Kinukawa N, Shimada M, et al. The role of p27kip1 protein expression on the biological behavior of intrahepatic cholangiocarcinoma. Hepatology 2001;33:1118-23.
27. Sugimachi K, Aishima S, Taguchi K, Tanaka S, Shimada M, Kajiyama K, et al. The role of overexpression and gene amplification of cyclin D1 in intrahepatic cholangiocarcinoma. J Hepatol 2001;35:74-9.
28. Terada T, Nakanuma Y, Ohta T, Nagakawa T. Histological features and interphase nucleolar organizer regions in hyperplastic, dysplastic and neoplastic epithelium of intrahepatic bile ducts in hepatolithiasis. Histopathology 1992;21:233-40.
29. Koga A, Ichimiya H, Yamaguchi K, Miyazaki K, Nakayama F. Hepatolithiasis associated with cholangiocarcinoma. Possible etiologic significance. Cancer 1985;55:2826-9.
30. Crowe DL, Milo GE, Shuler CF. Keratin 19 downregulation by oral squamous cell carcinoma lines increases invasive potential. J Dent Res 1999;78:1256-63.
31. Kouklis PD, Hutton E, Fuchs E. Making a connection: Direct binding between keratin intermediate filaments and desmosomal proteins. J Cell Biol 1994;127:1049-60.
32. Bornslaeger EA, Corcoran CM, Stappenbeck TS, Green KJ. Breaking, the connection: Displacement of the desmosomal plaque protein desmoplakin from cell-cell interfaces disrupts anchorage of intermediate filament bundles and alters intercellular junction assembly. J Cell Biol 1996;134:985-1001.
33. Yancey KB. Adhesion molecules. II. Interactions of keratinocytes with epidermal basement membrane. J Invest Dermatol 1995;104:1008-14.
34. Matsumoto S, Yamamoto K, Nagano T, Okamoto R, Ibuki N, Tagashira M, et al. Immunohistochemical study on phenotypical changes of hepatocytes in liver disease with reference to extracellular matrix composition. Liver 1999;19:32-8.